Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rivaroxaban in patients with mechanical heart valve replacement
IRCT20240411061471N1Phase 2Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of rivaroxaban, sponsored by Isfahan University of Medical Sciences. Started Dec 2024; status: completed.
02
Drugs
rivaroxaban
Beyond the preview
Go deeper on IRCT20240411061471N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240411061471N1.